Clinical Trial Update: Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin [Phase 2]

View source ↗

Summary

Phase 2 trial of temozolomide in patients with metastatic germ cell tumors that did not respond to cisplatin has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Testicular Germ Cell Tumor

Drugs mentioned

• Temodar (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Ovarian Cancer, Testicular Germ Cell Tumor | Phase 2 | Status: COMPLETED